Interestingly, research suggests that there are metabolic disorders of SA1P and S1P in both the brain and plasma in AD and confirms that SA1P and S1P in plasma and brain have great potential as biomarkers for AD [86,87]. The gene discussed is MBTPS1; the disease is Alzheimer disease.